Results 191 to 200 of about 180,278 (321)

The Structural Biology of T-Cell Antigen Detection at Close Contacts. [PDF]

open access: yesImmunol Rev
Lui Y   +5 more
europepmc   +1 more source

Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specificMAGE-2 gene product [PDF]

open access: bronze, 1997
Marjan J.W. Visseren   +8 more
openalex   +1 more source

Role of radiotherapy in surgical approaches to pancreatic cancer treatment: A narrative review

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This review explores the role of radiotherapy (RT) in the multidisciplinary treatment of pancreatic ductal adenocarcinoma (PDAC), focusing on its integration with surgical strategies to improve resectability, local control, and survival outcomes while addressing potential challenges and future research directions.
Satoshi Yasuda   +4 more
wiley   +1 more source

Planar Tetracoordinate Oxygen Atoms

open access: yesAngewandte Chemie, EarlyView.
This study investigates 515 candidate structures featuring a planar tetracoordinate oxygen (ptO) atom, adhering to the 18 valence electron rule and formulated as OXnYmq. Among these, 35 global minima were identified, primarily stabilized by Group 13 elements with charge states spanning −1 to +1.
Gabriela Castillo‐Toraya   +5 more
wiley   +2 more sources

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah   +2 more
wiley   +1 more source

Antigen targeting to dendritic cells: Still a place in future immunotherapy?

open access: yesEuropean Journal of Immunology, Volume 52, Issue 12, Page 1909-1924, December 2022., 2022
Dendritic cell‐based immunotherapy is a promising vaccination strategy to treat infectious diseases, autoimmunity, and cancer. In this review, we present an overview on the current state of antigen targeting approaches via C‐type lectin receptors, with an outlook on future developments and potential for clinical translation.
Patrizia Stoitzner   +4 more
wiley   +1 more source

Antibody for tumor related mucin and CTL.

open access: bronze, 1993
高橋 徹   +3 more
openalex   +2 more sources

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley   +1 more source

Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells

open access: yesEuropean Journal of Immunology, Volume 52, Issue 12, Page 1880-1888, December 2022., 2022
Somatic cells (fibroblasts, dendritic cells, T cells) are reprogrammed into induced pluripotent stem cells (iPS cells) with specific transcription factors. iPS cells are then differentiated into iPS cell‐derived DC (ipDC) with DC inducing cytokines. Fibroblasts are directly reprogrammed into induced DC (iDC) by DC specific transcription factors (direct
Niclas Flosdorf, Martin Zenke
wiley   +1 more source

Home - About - Disclaimer - Privacy